Anbio Biotechnology (NNNN) Shares Outstanding (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Shares Outstanding (Entity) of $43.7 million for Q4 2025, up 3.27% year-over-year from $42.3 million in Q4 2024, and up 0.51% quarter-over-quarter from $43.4 million in Q2 2025.
Anbio Biotechnology (NNNN) Shares Outstanding (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Shares Outstanding (Entity) for 3 consecutive years, with $43.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 3.27% year-over-year to $43.7 million; the TTM figure through Dec 2025 stood at $43.7 million (up 3.27% YoY), while the FY2025 annual figure was $43.7 million, up 3.27% from the prior year.
- Shares Outstanding (Entity) improved to $43.7 million in Q4 2025 per NNNN's latest filing, from $43.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $43.7 million in Q4 2025 and bottomed at $21.4 million in Q4 2023.
- Historically, Shares Outstanding (Entity) has averaged $37.7 million across 3 years, with a median of $42.9 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) soared 97.3% — and 2025, when it increased 3.27%.
- Anbio Biotechnology's Shares Outstanding (Entity) stood at $21.4 million in 2023, then jumped by 97.3% to $42.3 million in 2024, then rose by 3.27% to $43.7 million in 2025.
- Business Quant data shows NNNN's Shares Outstanding (Entity) at $43.7 million in Q4 2025, $43.4 million in Q2 2025, and $42.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Anbio Biotechnology | 301.77 Mn | 289.87 Mn | - | 43.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.67 Mn |
| Jun 30, 2025 | 43.45 Mn |
| Dec 31, 2024 | 42.29 Mn |
| Dec 31, 2023 | 21.44 Mn |